檢定因DNA甲基化變異而造成台灣大腸癌發生及惡化之新穎抑癌基因及致癌基因以及應用於抗癌藥物之研發(1/3)

Biochemistry, Genetics and Molecular Biology

1. DNA Methylation 100%
2. Colon 100%
3. Methylation 66%
4. Carcinogenesis 26%
5. CpG Island 13%
6. Promoter Region 13%
7. Cell Proliferation 13%
8. Cancer Mortality 13%
9. Messenger RNA 13%
10. Blood Plasma 13%
11. Colony Formation 6%
12. Enzyme 6%
13. Disease Free Survival 6%
14. DNA Methyltransferase 6%
15. Transient Transfection 6%
16. mRNA Expression Level 6%
17. Oncogene 6%
18. Small Interfering RNA 6%
19. Cancer Cell 6%
20. Cell Cycle Progression 6%
21. Protein Expression Level 6%
22. Mortality Rate 6%
23. Demethylase 6%
24. RNA 6%
25. Methyltransferase 6%
26. Tumor Suppressor Gene 6%
27. Protein Expression 6%
28. Normal Human 6%
29. Transcription Initiation 6%
30. Thymine-DNA Glycosylase 6%
31. Recurrence Free Survival 6%
32. Chemosensitivity 6%
33. Genomics 6%
34. Transactivation 6%
35. Anticancer 6%
36. Programmed Cell Death 6%
37. Dioxygenase 6%

Pharmacology, Toxicology and Pharmaceutical Science

1. Malignant Neoplasm 100%
2. Colon Carcinoma 100%
3. Biological Marker 38%
4. Carcinogenesis 30%
5. Colorectal Carcinoma 30%
6. Neoplasm 23%
7. Messenger RNA 23%
8. Cancer Mortality 15%
9. Combination Therapy 15%
10. Thymine DNA Glycosylase 7%
11. DNA Methyltransferase 7%
12. Disease Free Survival 7%
13. Small Interfering RNA 7%
14. Chemotherapy 7%
15. Colorectal Tumor 7%
16. Dioxygenase 7%
17. Mortality Rate 7%
18. Normal Human 7%
19. Recurrence Free Survival 7%
20. Adenocarcinoma 7%
21. Methyltransferase 7%
22. Tumor Suppressor Protein 7%